Please login to the form below
HAS
This page shows the latest HAS news and features for those working in and with pharma, biotech and healthcare.
Novartis forges AI alliance with Oxford University
Part of Novartis drive to become 'data-driven' pharma company. Novartis has entered into a five-year collaboration with Oxford University to apply artificial intelligence to predicting how patients respond to ... This has the potential to transform how
Latest news
-
FDA adcomm split on Sanofi’s type 1 diabetes drug
The FDA convened an advisory committee meeting to help its review of Sanofi’s diabetes drug Zynquista, but has ended up with a split decision that means it effectively has the ... It is also a key element in Sanofi’s plans to rebuild its diabetes
-
Europe closer to biosimilar rule change, despite fierce resistance from pharma
The European Commission has a very contrasting view, and says the rules will help Europe’s competitiveness as a hub for pharmaceutical R&D and manufacturing.
-
NICE gives Lilly’s Verzenios chance to compete with rivals
Ibrance and Verzenios gained NICE approval in November 2017, which means Lilly has some catching up to do. ... Abemaciclib has been shown to be just as effective as palbociclib and ribociclib, but can come with slightly different side effects.
-
Evenity back on track with FDA panel blessing in osteoporosis
While the FDA still has the final say on full approval, the bone-building drug seems to have finally shaken off the cardiovascular safety concerns that caused the agency to reject ... Amgen has already secured its first marketing approval for Evenity
-
J&J’s Erleada cleared for early prostate cancer in Europe
patients show no evidence that the cancer has spread at the time that status is diagnosed. ... For patients however, it means a new choice of treatments for a critical stage of prostate cancer that currently has few treatment options.
More from news
Approximately 1 fully matching, plus 7,155 partially matching documents found.
Latest Intelligence
-
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
France has a national plan that aims to improve care pathways for patients with neurodegenerative disorders. ... Italy has launched a project to identify patients with the highest risk of developing Alzheimer’s dementia to improve coordination and
-
The UK’s new five-year pricing agreement
In my mind, the industry negotiating team has achieved what once looked to be impossible. ... And that is why I think the industry negotiating team should be congratulated on the job it has done.
-
Escaping the spin cycle of sub-optimal launch
There is no template for this – every launch has its own set of success factors.”. ... Our own research has found that while companies are good at identifying and developing deep customer insights, there’s room for improvement in how those insights
-
Relearning launch: Four key dynamics for pharma launches in 2019
In the US, continued consolidation of both payers and providers has created significant disparity between regions in everything from metrics to access to approach to care. ... In this new era, initial value has to be realised more quickly, and
-
Launch like a PRO: the art and science of successful entry to market
Scenario planning. Launch planning frequently has to address complex and unpredictable markets.
More from intelligence
Approximately 0 fully matching, plus 830 partially matching documents found.
Latest appointments
-
New faces at Lucid, 90Ten and Page & Page
Lucid Group has appointed Rob Apollo as its new Director of Corporate Development. ... Bates has 17 years’ experience developing content for pharmaceutical and medical device industries.
-
New hires at Nanoform, Leo Pharma and Calliditas
My career has focused on enhancing the commercial application of research, and Nanoform’s use of cutting-edge nanonization technology exemplifies how innovations are transforming the sector.”. ... He has previously worked in various positions at Novo
-
Changes at Oxford PharmaGenesis, Reynolds-Mackenzie and more
Independent HealthScience communications consultancy Oxford PharmaGenesis has appointed Corin Wing as a Principal Medical Writer. ... Meanwhile Ramkali has been responsible for the agency’s life science client since 2011.
-
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO
It’s a newly created role, which the company has said will significantly strengthen Nanoform’s commercial organisation. ... Tara Rheault. Rheault has more than 16 years of cross-functional leadership experience across drug discovery and development.
-
EM Imaging appoints new chairman
The Board of Edinburgh Molecular Imaging (EM Imaging) has appointed John Jeans as non-executive chairman. ... Jeans also chairs the board of UK Biocentre, and has sat on advisory panels for the MRC, EPSRC, NIHR and the Wellcome Trust. .
More from appointments
Approximately 0 fully matching, plus 1,004 partially matching documents found.
Latest from PMHub
-
Research Partnership has published a new patient Living with Atopic Dermatitis (US) report
Living with Atopic Dermatitis (AD) is a report based on a new study conducted amongst adult sufferers and parents of child sufferers. The report consists of 45-minute quantitative and 30-minute qualitative interviews with 152 AD sufferers in total.
-
Mednet Group’s growth spurt
in cancer biology and she has experience working as a research technician in the field of malignant haematology. . ... We are also excited to welcome Nisha, who has join Mednet Group in the role of Medical Writer.
-
Modernising the Mental Health Act: Published Today
The final report of the Independent Review of the Mental Health Act 1983 has been published today, 6th December 2018. ... The final report of the independent review of the Mental Health Act 1983 ‘Modernising the Mental Health Act’ has been published.
-
Porterhouse Medical rewards superb client service skills
Since joining the client services team as a senior account executive in 2013, Gema has consistently demonstrated her superb client service skills and commitment to her role. . ... It is a pleasure to see her career and leadership role progress,
-
Eoin McAtamney announced as Managing Director of Ashfield Ireland
Previously Eoin has gained sales experience in both the pharma and CSO environments. ... Ashfield has built up a strong reputation in the market, characterised by the quality of both the people and the service it provides.
More from PMHub
Approximately 0 fully matching, plus 1,018 partially matching documents found.
Featured jobs
-
Senior Account Manager
-
Competitive Salary Offered
- Senior Account Manager, Rare Diseases – Medical Communications, ...
-
Excellent package
- Account Manager / Senior Account Manager
-
35, 000-40, 000
-
Account Manager / Account Director
-
Competative
- Global Business Development Director – Health Education
-
excellent commission
-
Business Director
-
Competitive Salary Offered
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
- Engagement Expert, Healthcare Brand Communications, London
-
Excellent package
-
Senior Medical Writer
-
Salary TBC
-
Account Director
-
Competitive Salary Offered
-
Medical Writer
-
Salary TBC
- Senior Account Director development role to Business Director, H...
-
Excellent package
-
Associate Director
-
£75, 000-90, 000
-
Account Director, Medical Education
-
Salary TBC
Subscribe to our email news alerts
- Europe closer to biosimilar rule change, despite fierce resistance from pharma
- Novartis forges AI alliance with Oxford University
- FDA adcomm split on Sanofi’s type 1 diabetes drug
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Essential collaboration skills training for pharma and healthcare teams launched by Dovetail.
- Evenity back on track with FDA panel blessing in osteoporosis
PMHub
Conversis
Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...
Latest intelligence
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Healthcare leaders in the European Union should begin preparing for a breakthrough now...
- The UK’s new five-year pricing agreement
- Pharma has agreed to capped growth again - in exchange for uptake promises...
- Digital applications are transforming the market access landscape
- Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Quick links
Infographics
